Lack of independent association between fatty pancreas and incidence of type 2 diabetes: 5-Year Japanese cohort study

Diabetes Care

Volumn 39, Issue 10, 2016, Pages 1677-1683

  Yamazaki, Hajime ^a   Tsuboya, Toru ^b,c   Katanuma, Akio ^a   Kodama, Yoshihisa ^a   Tauchi, Shinichi ^d   Dohke, Mitsuru ^d   Maguchi, Hiroyuki ^a  

^a TEINE KEIJINKAI HOSPITAL   (Japan)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c TOHOKU UNIVERSITY   (Japan)

^d Maruyama Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUCOSE;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; DISEASE ASSOCIATION; FATTY PANCREAS; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; JAPANESE (PEOPLE); LIVER ATTENUATION; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ATTENUATION; PANCREAS DISEASE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; UNENHANCED COMPUTER ASSISTED TOMOGRAPHY; ADIPOSE TISSUE; AGED; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIAGNOSTIC IMAGING; PANCREAS; PATHOLOGY; RISK FACTOR; X-RAY COMPUTED TOMOGRAPHY;

ADIPOSE TISSUE; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PANCREAS; PANCREATIC DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84988975839     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-0074     Document Type: Article

References (29)

1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980- 2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384: 766-781
2. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology 2007;132:2087-2102
3. Smits MM, van Geenen EJ. The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol 2011;8:169-177
4. Wong VW, Wong GL, Yeung DK, et al. Fatty pancreas, insulin resistance, and β-cell function: A population study using fat-water magnetic resonance imaging. Am J Gastroenterol 2014; 109:589-597
5. Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 2013;10:330-344
6. Targher G, Byrne CD. Clinical review: nonalcoholic fatty liver disease: A novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab 2013; 98:483-495
7. Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome. Dig Liver Dis 2015;47:181-190
8. Yamazaki H, Tsuboya T, Tsuji K, Dohke M, Maguchi H. Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes. Diabetes Care 2015;38:1673-1679
9. van Raalte DH, van der Zijl NJ, Diamant M. Pancreatic steatosis in humans: Cause or marker of lipotoxicity?. Curr Opin Clin Nutr Metab Care 2010;13:478-485
10. Ou HY, Wang CY, Yang YC, Chen MF, Chang CJ. The association between nonalcoholic fatty pancreas disease and diabetes. PLoS One 2013; 8:e62561
11. Wang CY, Ou HY, ChenMF, Chang TC, Chang CJ. Enigmatic ectopic fat: Prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. J Am Heart Assoc 2014;3:e000297
12. Tushuizen ME, Bunck MC, Pouwels PJ, et al. Pancreatic fat content and β-cell function in men with and without type 2 diabetes. Diabetes Care 2007;30:2916-2921
13. HeniM,Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: A nuclear magnetic resonance study. Diabetes Metab Res Rev 2010;26:200-205
14. Yokota K, Fukushima M, Takahashi Y, Igaki N, Seino S. Insulin secretion and computed tomography values of the pancreas in the early stage of the development of diabetes. J Diabetes Investig 2012;3:371-376
15. Kühn JP, Berthold F, Mayerle J, et al. Pancreatic steatosis demonstrated atMRimaging in the general population: Clinical relevance. Radiology 2015;276:129-136
16. Sepe PS, Ohri A, Sanaka S, et al. A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc 2011;73:987-993
17. Kim SY, Kim H, Cho JY, et al. Quantitative assessment of pancreatic fat by using unenhanced CT: Pathologic correlation and clinical implications. Radiology 2014;271:104-112
18. Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 2007;20:933-942
19. Kodama Y, Ng CS, Wu TT, et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007;188: 1307-1312
20. Seino Y, Nanjo K, Tajima N, et al.; Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig 2010;1:212-228
21. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43:617-649
22. Narayan KM, Boyle JP, Thompson TJ, Gregg EW,Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007;30: 1562-1566
23. Ricci C, Longo R, Gioulis E, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997;27:108-113
24. Lee JS, Kim SH, Jun DW, et al. Clinical implications of fatty pancreas: Correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 2009;15:1869-1875
25. Wu WC, Wang CY. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: Case-control retrospective study. Cardiovasc Diabetol 2013; 12:77
26. Hu FB. Globalization of diabetes: The role of diet, lifestyle, and genes. Diabetes Care 2011; 34:1249-1257
27. Noda M, Kato M, Takahashi Y, et al. Fasting plasma glucose and 5-year incidence of diabetes in the JPHC diabetes study - suggestion for the threshold for impaired fasting glucose among Japanese. Endocr J 2010;57:629-637
28. Limanond P, Raman SS, Lassman C, et al. Macrovesicular hepatic steatosis in living related liver donors: Correlation between CT and histologic findings. Radiology 2004;230:276-280
29. van Werven JR, Marsman HA, Nederveen AJ, et al. Assessment of hepatic steatosis in patients undergoing liver resection: Comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 2010;256:159-168